FDA Approvals in Oncology: October-December 2024
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
Tag: Lung cancer
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
The AACR Industry Roundtable 2024 focused on topics related to tracking and treating early cancers, including predicting cancer risk...
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
LGBTQ+ cancer survivors offer lessons learned, and a researcher explains the odds of chronic conditions in LGBTQ+ survivors.
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
The U.S. Centers for Disease Control and Prevention (CDC) estimate that 80 to 90 percent of deaths from lung...
When diagnosed early, lung cancer can often be treated with surgical resection. However, patients with resectable non-small cell lung...
By Nicholas Warren, PhD Lung cancer is the deadliest cancer in the United States, killing more than 135,000 Americans...